← Leaderboards
Krishna Pl Bhat
University Of Tx Md Anderson Can Ctr
$3,427,143
Attributed
$6,453,541
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,453,541 · 4
By mechanism
R01$6,052,797 · 3
R21$400,744 · 1
Top collaborators
- Erik Sulman8 shared
- Wenbo Li3 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Jian Hu$8,609,311
- Rugang Zhang$23,913,209
- Joseph H McCarty$11,299,070
- Kenneth D Aldape$5,324,555
- Juan Fueyo$8,546,462
Others in their field
Other Emerging Leaders on “Malignant Neoplasm Of Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- Greg Yothers · University Of Chicago$35,003,821
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$15,459,738
- Crystal Mackall · Children'S Hosp Of Philadelphia$13,993,653
- Olwen Hahn · Brigham And Women'S Hospital$13,557,463
- Jennifer Cohen Price · University Of California, San Francisco$9,197,178
Research focus
Malignant Neoplasm Of BrainGlioblastomaMediatingBrain NeoplasmsGliomaAdultStem-Like CellGrowthNeoplastic CellMolecular SubtypesTumorTherapy ResistantXenograft ProcedureMolecularMalignant NeoplasmsRecurrencePlayBindingAmericanIn VivoIonizing RadiationIn VitroMesenchymalGene Expression Profile
Grant awards (13)
Exploiting cell fate transition to overcome radiation resistance in glioblastoma$676,623
R01 · FY2025 · CA
Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma$439,965
R01 · FY2025 · NS · contact PI
Exploiting cell fate transition to overcome radiation resistance in glioblastoma$652,198
R01 · FY2024 · CA
Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma$427,263
R01 · FY2024 · NS · contact PI
Exploiting cell fate transition to overcome radiation resistance in glioblastoma$709,593
R01 · FY2023 · CA
Bidirectional interaction of platelets and tumor cells in patients with glioblastoma$560,515
R01 · FY2023 · CA
Novel Roles of TAZ and YAP in DNA Damage Repair with 3D Genome Organization and the Therapeutic Resistance in Glioblastoma$455,465
R01 · FY2023 · NS · contact PI
Bidirectional interaction of platelets and tumor cells in patients with glioblastoma$560,514
R01 · FY2022 · CA
Bidirectional interaction of platelets and tumor cells in patients with glioblastoma$571,954
R01 · FY2021 · CA
Bidirectional interaction of platelets and tumor cells in patients with glioblastoma$490,666
R01 · FY2020 · CA
Developing a NF-κB/GADD45b targeting strategy for glioblastoma$176,447
R21 · FY2020 · CA · contact PI
Bidirectional interaction of platelets and tumor cells in patients with glioblastoma$508,041
R01 · FY2019 · CA
Developing a NF-κB/GADD45b targeting strategy for glioblastoma$224,297
R21 · FY2019 · CA · contact PI